Purchase the ATMP report at www.evernowpublishing.com

Subscribe to MedNous and get ahead in the business of medical innovation. Subscribe now.

The latest MedNous journal. Subscribe to download.

Abcam gets rights to research tools from Roche

Country: United Kingdom

UK-based Abcam Plc has gained exclusive rights to a portfolio of laboratory tools from Roche giving it a new source of recombinant antibodies for use by its customers in research. The financial terms of the agreement were not disclosed.

Read more

Nanobiotix reports data in liver cancer

Country: France

An early-stage trial of a medicine designed to enhance the effects of radiotherapy has produced promising data from patients with liver cancers. The medicine, NBTXR3, achieved a complete response in three out of seven patients who were eligible for evaluation.

Read more

Fiona Marshall steps down from Sosei

Country: Japan

Read more

Avacta partners with Glythera

Country: United Kingdom

Read more

Novo makes unsolicited bid for Ablynx

Country: Belgium

Read more

New delivery for gene therapy

Country: United States

Read more

CureVac expands therapeutic reach

Country: Germany

Read more

Takeda to acquire cell therapy company TiGenix

Country: Belgium

Read more

Rewind Therapeutics launched to treat MS

Country: Belgium

Read more

Addex partners to treat addiction

Country: Switzerland

Read more

iTeos Therapeutics regains rights to IDO1 inhibitor

Country: Belgium

Read more

BioNTech raises $270 million for cancer vaccines

Country: Germany

Read more

Looking for more?

Visit our news section for more articles.

News
Our full Mednous news archive
Appointments
Latest industry appointments
Events
A list of upcoming industry events

About Mednous

MedNous is a print publication and a website for everyone involved in medical research in Europe.

Read more

Free Article

Building the next generation of gene transfer vectors by Michael Roberts

Gene transfer vectors Michael L Roberts January 2018.pdf

Highlights of the January 2018 MedNous issue

The January 2018 MedNous features:

Latest Mednous cover
  • Gene Editing
    Interview with Orchard Therapeutics
  • Commentary
    The three waves of gene therapy By Frank Schnieders
  • Research Strategy
    Building the next generation of gene transfer vectors By Michael Roberts
  • Oncology Review
    Global oncology drug approvals accelerate By Bruno Pagliara
  • Biotech Finance
    BioNTech raises $270 million for cancer vaccines
  • Regenerative Medicine
    Takeda to acquire TiGenix
  • Quarterly Stock Market Review
    Biotechs buoyed by share issues

The latest MedNous journal. Subscribe to download.